Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $63.56 USD
Change Today +1.02 / 1.63%
Volume 593.6K
As of 8:10 PM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

amsurg corp (AMSG) Key Developments

AmSurg Corp. Announces Unaudited Consolidated Financial Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Second Quarter of 2015 and Revises Earnings Guidance for the Full Year of 2015

AmSurg Corp. announced unaudited consolidated financial results for the first quarter ended March 31, 2015. For the quarter, the company reported net revenue of $570,445,000 against $259,561,000 a year ago. Operating income was $113,251,000 against $79,988,000 a year ago. Earnings from continuing operations before income taxes were $83,004,000 against $73,028,000 a year ago. Net earnings from continuing operations were $68,755,000 or $0.39 per diluted share against $60,046,000 or $0.54 per diluted share a year ago. Net earnings were $68,755,000 or $0.39 per diluted share against $60,114,000 or $0.54 per diluted share a year ago. Net earnings attributable to company’s common shareholders were $18,774,000 against $17,195,000 a year ago. Adjusted net earnings were $31,733,000 or $0.62 per share against $18,311,000 or $0.57 per share a year ago. EBITDA was $88,352,000 against $45,593,000 a year ago. Adjusted EBITDA was $93,755,000 against $46,006,000 a year ago. Net cash flows provided by operating activities were $98,827,000 against $69,819,000 a year ago. Acquisition of property and equipment was $14,783,000 against $7,038,000 a year ago. The company has raised its financial and operating guidance for 2015 and established its financial guidance for the second quarter of the year. The company expects revenue in a range of $2.46 billion to $2.49 billion, up from a range of $2.44 billion to $2.47 billion; same-center revenue increase of 2% to 3% for Ambulatory Services, compared with the prior range of 1% to 3%; contract organic revenue growth of 6% to 8% in Physician Services, up from a range of 5% to 7%; adjusted EBITDA of $454 million to $460 million, up from a range of $445 million to $451 million; adjusted EPS in a range of $3.31 to $3.39, up from a range of $3.24 to $3.32. For the second quarter of 2015, the company expects adjusted EPS in a range of $0.81 to $0.84.

AmSurg Corp. Proposes Amendment to Second Amended and Restated Charter

AmSurg Corp. announced that at the AGM to be held on May 20, 2015, it will consider the proposal to approve amendment to second amended and restated charter, as amended, to increase authorized shares of capital stock from 75,000,000 to 125,000,000, to increase the authorized shares of common stock, no par value, from 70,000,000 to 120,000,000 and remove the designation of the preferences, limitations and rights of the Series C Junior Participating Preferred Stock, and to adopt articles of amendment to second amended and restated charter to reflect this amendment.

AmSurg Corp. to Report Q1, 2015 Results on May 05, 2015

AmSurg Corp. announced that they will report Q1, 2015 results at 5:00 PM, Eastern Standard Time on May 05, 2015

AmSurg Corp., Q1 2015 Earnings Call, May 06, 2015

AmSurg Corp., Q1 2015 Earnings Call, May 06, 2015

AmSurg Corp. Declares Quarterly Preferred Stock Dividend, Payable on April 1, 2015

AmSurg Corp. announced that its board of directors has declared a quarterly dividend of $1.3125 per share in cash for the Company's 5.250% mandatory convertible preferred stock, series A-1. The dividend is payable on April 1, 2015, to shareholders of record as of March 15, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMSG:US $63.56 USD +1.02

AMSG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
HealthSouth Corp $41.81 USD -0.14
LifePoint Hospitals Inc $69.70 USD -1.27
Providence Service Corp/The $41.32 USD -0.70
Surgical Care Affiliates Inc $37.83 USD +0.49
Team Health Holdings Inc $58.40 USD -0.47
View Industry Companies
 

Industry Analysis

AMSG

Industry Average

Valuation AMSG Industry Range
Price/Earnings 50.3x
Price/Sales 1.9x
Price/Book 2.0x
Price/Cash Flow 27.2x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMSURG CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.